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Equine herpesvirus type 1 (EHV-1) possesses a sole, diploid immediate-early (IE) gene that encodes a major regulatory
protein of 1487 amino acids capable of modulating expression of both early and late EHV-1 promoters and capable of
trans-repressing its own promoter. In this study, a rabbit kidney cell line (IE13.1) that constitutively expresses the EHV-1 IE
protein was generated by cotransfection of rabbit kidney (RK-13) cells with the viral IE gene and a neomycin resistance
marker. The IE protein expressed by this cell line was shown (1) to be expressed by and to localize to the nucleus of virtually
all cells as demonstrated by indirect immunofluorescence, (2) to be the full-size IE polypeptide as judged by Western
immunoblot analyses with an anti-IE protein-specific antibody, and (3) to be functional as shown by the transactivation of two
representative EHV-1 early promoters linked to the chloramphenicol acetyltransferase reporter gene in transient transfection
assays. The IE13.1 cell line was able to complement a recombinant virus in which both copies of the IE gene were replaced
by insertion of the Escherichia coli lacZ gene. This IE deletion mutant, designated KyADIE, was not able to replicate in equine,
rabbit, or mouse cells but was capable of replication in the IE13.1 cells that provided the IE protein in trans. Rescue of the
KyADIE virus was achieved by recombination with a marker plasmid that harbors the wild-type IE gene, and the rescued virus
(KyADIER) was able to grow on noncomplementary cells. Overall, these results offer direct evidence that the IE gene is
essential for EHV-1 replication and provide reagents useful for the analysis of IE protein function. © 1998 Academic Press
INTRODUCTION
EHV-1 possesses a sole diploid immediate-early (IE)
gene (IR1) that maps within each of the two inverted
repeats (IRs) (Grundy et al., 1989). The IE gene has been
sequenced to reveal a major open reading frame (ORF)
of 4461 bp that is transcribed to a 6.0-kb spliced mRNA
that gives rise to multiple antigenically and structurally
related protein species (Grundy et al., 1989; Harty et al.,
1989, 1990; Caughman et al., 1988). The largest and most
abundant IE protein species has a predicted molecular
mass of ;155 kDa. However, this species migrates
anomalously on sodium dodecyl sulfate (SDS)-polyacryl-
amide gels with an apparent molecular mass of 190–200
kDa (Caughman et al., 1985, 1988).
Characterization of the regulatory functions of the
EHV-1 IE protein has demonstrated that the IE gene
encodes a bifunctional regulatory protein that is capable
of both activation and repression of EHV-1 gene expres-
sion (Smith et al., 1992). The IE gene product is capable
of down-regulating gene expression directed by its own
promoter, activating gene expression directed by EHV-1
early promoters, and cooperating in a synergistic fashion
with accessory regulatory proteins of EHV-1 to induce
gene expression directed by early and late viral promot-
ers (Zhao et al., 1995; Smith et al., 1992, 1993, 1994;
Matsumura et al., 1993; Holden et al., 1995; O’Callaghan
and Osterrieder, 1998). The IE protein contains a potent
transactivation domain that maps within the first 89
amino acid residues, whereas investigation of the DNA
binding properties of the IE protein has revealed that the
DNA binding activity resides within residues 422–597
(Smith et al., 1994; Kim et al., 1995). Furthermore, amino
acids spanning 963–970 of the IE protein have been
shown to be necessary for nuclear localization (Smith et
al., 1995). Immunological studies using a panel of mono-
clonal antibodies defined at least three reactive epitopes
within a region spanning amino acids 323–522 and re-
vealed that both the IE protein and the IR2 protein, a
truncated form of the IE protein lacking the transactiva-
tion domain (Harty and O’Callaghan, 1991), were present
in virions (Caughman et al., 1995).
The generation of viruses containing mutant forms of
the IE protein would be important to elucidate further the
functions of the EHV-1 IE protein during the course of a
productive infection. Viruses containing mutant forms of
the IE genes of herpes simplex virus type 1 (HSV-1) have
been characterized and have been critical reagents for
explicating the various roles of the five IE proteins (Post
and Roizman, 1981; DeLuca et al., 1984, 1985; Sears et
al., 1985; Sacks and Shaffer, 1987). Initial studies to
elucidate the regulatory functions of the IE protein pro-
vided indirect evidence that suggested that IE gene ex-
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pression was essential for gene programming because a
cycloheximide block of translation of the IE mRNA pre-
cluded detectable expression of all other viral genes
(Caughman et al., 1985). In this study, a mammalian cell
line expressing the EHV-1 IE protein was used to gen-
erate a deletion mutant in which both copies of the IE
gene were replaced with lacZ sequences derived from
Escherichia coli. It is shown here that the IE gene is
essential for virus growth in cell culture and that inser-
tion of the IE gene into an IE null mutant restores its
growth in noncomplementary cells.
RESULTS
Establishment of a cell line expressing the EHV-1
IE protein
It is proposed that the IE protein performs an essential
replicative function. To propagate a mutant virus in which
the IE ORF has been deleted, a cell line was generated
that expresses the wild-type IE protein. Two plasmid
constructs were used to generate the IE protein-express-
ing cell line (Fig. 1). Construct pSR48, containing the
gene for geneticin (neomycin) resistance controlled by
the EHV-1 tk promoter, and construct pSVIE, containing
the entire IE ORF under the control of the SV40 promoter,
were linearized by ScaI digestion and cotransfected into
RK-13 cells in ratios ranging from 1:1 to 5:1, respectively
(Smith et al., 1992, 1994). Because the IE protein is able
to strongly transactivate the EHV-1 tk promoter, a selec-
tive pressure is placed on cells harboring both con-
structs to maintain production of the IE protein in the
presence of neomycin. As a control, RK-13 cells were
transfected with the pSV2neo construct harboring the
neomycin resistance gene under the control of the SV40
promoter. After 3–4 weeks, colonies surviving neomycin
selection (800 mg/ml) were picked, expanded, and ana-
lyzed for the expression of the EHV-1 IE protein. Individ-
ual clones were tested by IF analyses using a polyclonal
anti-IE peptide antibody to determine the extent of IE
protein production. IF analyses detected high expression
of the IE protein and showed an intense nuclear staining
pattern in IE protein-producing RK-13 cells (Fig. 2). Six
cell lines were isolated that demonstrated IE protein
production by IF analyses, although the extent of IE
protein production in each of the cell lines varied. One
cell line in particular, designated IE13.1, produced exten-
sive amounts of the IE protein in the nuclei of .95% of
the cells even after extensive passage and was chosen
for further characterization. In contrast, no staining could
be detected in cell lines derived from RK-13 cells trans-
fected with the pSV2neo construct alone (designated
RKNeo; Fig. 2).
Although IF analyses clearly detected a reactive pro-
tein in the nuclei of IE13.1 cells, it was possible that these
cells produced a truncated form of the IE protein con-
taining the nuclear localization domain. To rule out this
possibility, Western blot analyses were performed using
protein extracts derived from IE13.1 cells. RKNeo cell
extracts were generated to serve as a negative control,
whereas extracts derived from EHV-1-infected RK-13
cells (4 h p.i.) were generated to serve as a positive
control. Each extract was run on 8% SDS-polyacrylamide
gels, blotted onto nitrocellulose, and stained with the
polyclonal anti-IE peptide antibody (Fig. 3). Western blot
analyses using the anti-IE peptide antibody detected a
reactive protein migrating at 200 kDa in extracts derived
from the IE13.1 cell line (lane 2) and EHV-1-infected RK-13
cells (lane 3). However, no reactive protein was detected
in extracts derived from RKNeo cells (lane 1). These
results clearly demonstrated that the IE13.1 cell line ex-
presses the full-length IE protein. Although the predicted
molecular mass of the 1487-amino-acid IE polypeptide is
155 kDa, the IE protein migrates anomalously on SDS-
polyacylamide gels with an apparent molecular mass of
200 kDa.
Transient transfection assays were conducted to de-
FIG. 1. Constructs used to generate an IE protein-producing cell line. pSR48 expresses the gene for neomycin resistance under the control of the
EHV-1 tk promoter, whereas the pSVIE construct expresses the entire IE ORF under the control of the SV40 promoter. Varying concentrations of both
constructs were cotransfected into rabbit kidney cells (RK-13). Cells surviving neomycin selection (800 mg/ml) were picked and expanded.
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FIG. 2. Immunofluorescence analyses of the IE protein-producing cell line IE13.1. Cells were fixed in 80% acetone and stained with a polyclonal
anti-IE peptide antibody followed by staining with an anti-rabbit antibody conjugated to fluorescein isothiocyanate.(A) RK-13 cells transfected with
pSV2neo alone. (B) RK-13 cells transfected with both pSR48 and pSVIE. The IE protein localizes to the nucleus in 195% of the IE13.1 cells even after
continuous passage.
FIG. 6. Growth of KyADIE. RK-13 and IE13.1 cells were infected with KyADIE at various 10-fold dilutions ranging from undiluted to 1025 pfu/ml. (A)
KyADIE plated onto RK-13 cells. (B) KyADIE plated onto IE13.1 cells. Cells were infected with each dilution of KyADIE, and after a 1-h attachment period
were overlaid with a 1:1 mixture of Eagle’s medium supplemented with 10% FBS and methylcellulose-4000. After 5 days, cells were fixed with 10%
buffered Formalin and stained with 0.1% methylene blue, and plaques were enumerated.(C) Growth curve analyses using wild-type KyA and KyADIE.
RK-13 cells were infected with either wild-type KyA (f) or KyADIE (l) at an m.o.i. of 1 and incubated for 1 h at 37°C in 5% CO2 to allow virus
attachment. After attachment, the cells were washed three times with PBS to remove unattached virus and were incubated at 37°C in 5% CO2. At the
times indicated after the 1-h attachment period, virus titers in the culture supernatant were determined by plaque assay using RK-13 cells.
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termine whether the IE protein produced in IE13.1 cells
was functional with regard to the ability to transactivate
EHV-1 viral genes. The IE protein is capable of transac-
tivating the EHV-1 tk gene to relatively high levels during
the course of a production infection (Smith et al., 1992,
1993). Therefore, the TK2-CAT construct, containing the
CAT reporter gene under the control of the EHV-1 tk
promoter, was used to assess the ability of the IE protein
expressed in IE13.1 cells to initiate CAT reporter expres-
sion. The TK2-CAT construct was cotransfected into ei-
ther RK-13 cells or the IE13.1 cell line. As demonstrated in
Figure 4, transfection of the TK2-CAT reporter construct
into IE13.1 cells resulted in a 44-fold induction of CAT
activity relative to levels obtained when constructs were
transfected into parental RK-13 cells. The ability of the IE
protein produced in IE13.1 cells to initiate CAT reporter
expression from the EICP22 promoter, another represen-
tative early viral promoter, also was assessed (Fig. 4).
EICP22-CAT was transfected in increasing increments
into either IE13.1 or RK-13 cells. Extracts of RK-13 cells
did not demonstrate activation of EICP22-CAT at any
concentration tested and exhibited levels of acetylation
comparable to those observed in nontransfected cells.
However, as the levels of EICP22-CAT transfected into
IE13.1 cells increased, there was a corresponding in-
crease in acetylation levels. Overall, acetylation levels in
IE13.1 cells transfected with EICP22-CAT were ninefold
above that observed for RK-13 cells transfected with the
EICP22-CAT construct (Fig. 4). These results and those
already presented (Figs. 2 and 3) demonstrated that the
IE protein synthesized in the IE13.1 cell line was similar
in size to the wild-type IE protein produced in EHV-1-
infected cells, was able to enter the nucleus efficiently
and in large amounts, and was capable of transactivating
representative EHV-1 early promoters.
Derivation of an IE null virus
An IE null virus was generated by homologous recom-
bination in IE13.1 cells cotransfected with infectious
EHV-1 DNA and a recombination vector designated
pFG65 that harbors both the 59 (nt 2813 to 1637) and 39
(nt 15740 to 18170) regions of the IE gene flanking the
bacterial lacZ gene. The 59 portion of the IE gene was
cloned in a manner such that the initiating ATG of the IE
ORF drives expression of the lacZ gene. The expanses of
IE sequences flanking the lacZ gene are sufficient to
support a stable recombination event such that the IE
ORF located on both IRs of the EHV-1 genome would be
replaced with the lacZ gene. EHV-1 genomic DNA and
plasmid pFG65 were cotransfected into IE13.1 cells at
plasmid-to-viral DNA molar ratios ranging from 1:1 to
15:1. Recombinant viruses in which both copies of the IE
gene had been replaced with the lacZ gene yielded
intense, blue-staining plaques within 3–5 days after
transfection. Approximately 17 blue plaques were picked
and subjected to six rounds of plaque purification to
purify putative null viruses. One virus clone, designated
KyADIE, was chosen for further analyses.
To determine whether the IE gene had indeed been
replaced with lacZ sequences on both IRs, viral genomic
DNA was isolated from KyADIE, and PCR experiments
were performed using two sets of primers designed to
amplify either lacZ-specific sequences or IE-specific se-
quences (Fig. 5). Both sets of primers were designed to
overlap the joint region in which lacZ would be inserted
into the IE ORF in either of the IRs. Primer set 1 would
amplify a 245-bp IE-specific DNA fragment from virus in
FIG. 4. Transient transfection assays using RK-13 cells and cell line
IE13.1. RK-13 cells and IE13.1 cells were transfected with either the
TK2-CAT (1.4 pmoles) or EICP22-CAT (1.4 pmoles) construct. Equal
amounts of cell lysate protein were analyzed by CAT assay to assess
reporter activity. CAT assay results were analyzed by PhosphorImager
scanning and were quantified using the ImageQuant program (Molec-
ular Dynamics, Sunnyvale, CA) to determine levels of acetylation. The
percentage of acetylation (average of three samples) was plotted, and
the error bars represent 61 SD.
FIG. 3. Western blot analyses of cell extracts from mock-infected
RK-13 cells, RK-13 cells expressing the IE protein (IE13.1 cells) and
RK-13 cells infected with EHV-1 KyA strain. Cell lysates were subjected
to SDS-PAGE, and the proteins were blotted to nitrocellulose that was
stained with the polyclonal anti-IE peptide antibody. Lane 1, RKNeo
cells. Lane 2, pSVIE- and pSR48-cotransfected RK-13 cells expressing
the EHV-1 IE protein (IE13.1 cells). Lane 3, EHV-1-infected RK-13 cells.
The 200-kDa band representing the IE protein was detected in extracts
derived from both the IE13.1 cell line and RK-13-infected cell extracts.
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which recombination failed to occur. Primer set 2 would
amplify a 175-bp lacZ-specific DNA fragment from virus
in which lacZ had replaced the IE ORF. As a control,
genomic DNA was isolated from virus pools that had
been initially isolated from flasks exhibiting CPE after
cotransfection of IE13.1 cells with KyA genomic DNA and
pFG65 and therefore would contain a mixture of both
wild-type and DIE null virus. Viral genomic DNA isolated
from wild-type EHV-1 served as a negative control for
lacZ sequences. PCR analyses confirmed the presence
of only lacZ sequences in KyADIE DNA samples,
whereas samples of DNA isolated before plaque purifi-
cation demonstrated the presence of both lacZ and in-
ternal IE ORF sequences. Only IE specific-sequences
could be detected in DNA samples isolated from wild-
type EHV-1. These findings clearly demonstrated that
internal IE sequences had indeed been replaced with
lacZ sequences in both IRs of the KyADIE virus. In addi-
tion, Southern blot analyses of these DNA samples using
either a lacZ-specific probe or an EHV-1 IE-specific
probe confirmed that the KyADIE DNA harbored only lacZ
sequence and failed to react with the IE-specific probe
(data not shown).
Growth analyses of KyADIE in RK-13 and IE13.1
cell lines
After PCR analyses, growth of the KyADIE virus was
tested by infecting both RK-13 and IE13.1 cells at varying
10-fold dilutions, ranging from undiluted to 1025. If the IE
gene encodes an essential regulatory protein, KyADIE
should propagate on the complementing IE13.1 cell line
but not on normal RK-13 cells. Plaques were detectable
on IE13.1 cells at all dilutions tested, whereas RK-13 cells
were unable to support growth of the KyADIE null virus at
any dilution (Figs. 6A and 6B). Finally, growth curve
FIG. 5. PCR analyses of KyADIE. PCR was performed using one of two primer sets as described in Materials and Methods. Primer set 1 amplifies
a 245-bp fragment representing internal IE sequences. Primer set 2 amplifies a 175-bp fragment specific for lacZ sequences. Mix, PCRs using viral
DNA isolated from initial, unpurified virus pools; KyA, PCRs using genomic DNA isolated from wild-type EHV-1 KyA strain; Null, PCRs using genomic
DNA isolated from plaque-purified KyADIE virus samples. All reactions were performed with the indicated primer set. See Materials and Methods for
details.
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analyses were performed to demonstrate definitively that
KyADIE could not propagate in noncomplementary RK-13
cells. RK-13 cells were infected with either wild-type KyA
or KyADIE at an m.o.i. of 1. Aliquots of culture superna-
tants were harvested at various times p.i. and titered on
RK-13 cells (Fig. 6C). Although no detectable virus was
observed at any time in culture supernatants obtained
from KyADIE-infected RK-13 cells, viral titers in KyA-in-
fected RK-13 cells reached levels of .107 log10 pfu/ml.
These results demonstrated that KyADIE could propa-
gate only on the IE13.1 cell line and clearly indicated the
IE gene was essential for EHV-1 growth in tissue culture.
In addition, the KyADIE virus failed to replicate in equine
(NBL-6 and ETCC) and mouse (LM) cell lines (data not
shown), as well as in the rabbit kidney cell line.
EHV-1 KyA- and KyADIE-infected cell protein
synthesis
Plaque assay and growth curve analyses indicated
that KyADIE is unable to grow in noncomplementary
cells. To confirm that viral proteins are not expressed
after infection of noncomplementary cells with KyADIE,
isotopic labeling was performed of KyA- or KyADIE-in-
fected RK-13 cells. Figure 7 (left) depicts the SDS-poly-
acrylamide gel electrophoresis (PAGE) profile of [35S]me-
thionine-labeled polypeptides synthesized during the
first 8 h of infection of RK-13 cells with wild-type KyA. The
protein profile derived from infected-cell extracts com-
pared with the profile of mock-infected extracts clearly
shows the synthesis of the IE protein at 200 kDa within
2 h p.i. The synthesis of a 42-kDa cellular protein, pre-
sumably actin, was also observed in both mock- and
KyA-infected extracts at all time points, although synthe-
sis of this protein was significantly reduced by 8 h p.i.
Additionally, the synthesis of other major viral proteins
(82, 35, and 31 kDa) not present in mock-infected extracts
is also evident during the course of cytocidal infection.
The profile of EHV-1-infected cell proteins depicted in
Figure 7 (left) is very similar to that described previously
by Caughman et al. (1985), who analyzed EHV-1-infected
cell polypeptides produced in cytocidal infection. The
profile of the EHV-1 KyA-infected cells differed markedly
from that of cells infected with KyADIE (right). The protein
profile of KyADIE-infected RK-13 cells at all time points
was virtually identical to that of mock-infected cells (Fig.
7, right) with the exception of the 115-kDa lacZ protein
(IElacZ), which was synthesized by 2 h p.i. These results
confirm that the IE protein is essential for EHV-1 replica-
tion because the absence of the IE protein precludes
early and late viral protein synthesis.
FIG. 7. Infected cell polypeptides (ICPs) synthesized in cells infected with EHV-1 KyA or KyADIE. RK-13 cells infected with KyA (wild-type virus) or
KyADIE (IE deletion mutant virus) were pulse labeled with [35S]methionine at 2-h intervals from 1 to 8 h p.i., and mock-infected RK-13 cells were labeled
at 0–2 h as described in Materials and Methods. Aliquots corresponding to 3 3 105 solubilized cells were prepared and subjected to SDS-PAGE
analysis in a 10% polyacrylamide gel. (Left) Protein profiles of EHV-1 KyA-infected cell extracts. The arrow indicates the position of the EHV-1 IE protein
that appears within 2 h p.i. *, Position of the 42K host protein. (Right) Protein profile of EHV-1 KyADIE-infected cell extracts. The arrow indicates the
position of the EHV-1 IElacZ protein that appears within 2 h p.i. The IElacZ protein is a fusion protein of the lacZ protein fused in frame to the 10 amino
acids of the C-terminus of the IE protein. *, Position of the 42K host protein. Note that the protein profiles of KyADIE-infected RK-13 cells do not differ
from those of mock-infected cells.
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Rescue of KyADIE
To confirm that the deletion of the IE gene was the sole
reason why the virus designated KyADIE failed to repli-
cate in noncomplementary cells, marker rescue experi-
ments were performed to restore a wild-type IE gene to
KyADIE. The IE ORF deletions in KyADIE were rescued
with plasmid pBR322IE, which contains the entire IE
gene (nt 2813 to 18170) derived from wild-type KyA. The
pBR322IE recombination construct was transfected into
IE13.1 cells in varying amounts ranging from 5 to 20 mg.
At ;24 h after transfection, IE13.1 cell monolayers were
superinfected with KyADIE at an m.o.i. of 10 and were
examined for CPE for up to 48 h. Infected cell superna-
tants were clarified to remove cellular debris and were
used at 10-fold dilutions ranging from undiluted to 1025
to infect RK-13 cell cultures, which were examined for
CPE for up to 7 days. The KyADIE virus was able to
propagate only on the IE13.1 cell line. In contrast, the
rescued null virus, KyADIER, replicated on both RK-13
cells and IE13.1 cells, and plaques were observed at all
dilutions tested. Approximately 10 plaques were picked
and subjected to five rounds of plaque purification on
RK-13 cells to remove residual KyADIE virus. Rescued
virus was isolated from each of the plaque-purified
stocks by ultracentrifugation, and samples were sub-
jected to PCR analyses using the primer sets as de-
scribed in Materials and Methods. As controls, culture
supernatants derived from uninfected RK-13 cells and
KyADIE-infected RK-13 cells were subjected to ultracen-
trifugation and prepared for PCR analyses. Genomic
DNA isolated from wild-type EHV-1 served as a positive
control for IE sequences, whereas genomic DNA derived
from KyADIE served as a positive control for lacZ se-
quences. PCR analyses of rescued KyADIE, designated
KyADIER, demonstrated only the presence of a 245-bp
IE-specific DNA fragment, and the 175-bp lacZ-specific
DNA product was not detected (Fig. 8, lanes 5 and 10).
Similarly, a 245-bp IE-specific DNA fragment was de-
tected when EHV-1 KyA genomic DNA served as a tem-
plate for PCR analyses (Fig. 8, lane 2). A 175-bp lacZ-
specific DNA fragment was detectable only in samples
containing KyADIE genomic DNA (Fig. 8, lane 8). No
detectable DNA fragments specific for IE or lacZ se-
quences were observed in samples of supernatants from
FIG. 8. PCR analyses of KyADIE. PCR was performed using one of two primer sets as described in Materials and Methods. Primer set 1 amplifies
a 245-bp fragment representing internal IE sequences. Primer set 2 amplifies a 175-bp fragment specific for lacZ sequences. The 1-kb DNA ladder
(lanes 1 and 6), KyA genomic DNA (lanes 2 and 7), KyADIE genomic DNA (lanes 3 and 8), DNA isolated from supernatants of KyADIE-infected RK-13
cells (lanes 4 and 9), and virion DNA isolated from KyADIER-infected RK-13 cells (lanes 5 and 10) were analyzed by PCR using the indicated primer
sets. KyADIER demonstrated only IE-specific sequences.
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RK-13 cells infected with KyADIE because virus replica-
tion did not occur (Fig. 8, lanes 4 and 9). These data
indicated that in the rescued virus, both copies of the
bacterial lacZ ORF of KyADIE had been replaced with the
wild-type IE ORF derived from the pBR322IE recombina-
tion vector. The finding that replacement of the lacZ ORF
with the EHV-1 IE allele restored the replicative function
confirmed that the failure of KyADIE to replicate was due
solely to the deletion of the IE gene.
Growth analyses of KyADIE in RK-13 cells
Growth curve analyses were performed to deter-
mine whether KyADIE could grow efficiently in RK-13
cells and yield virus titers comparable to those ob-
served with wild-type EHV-1. RK-13 cells were infected
with either wild-type KyA or KyADIER at an m.o.i. of 1,
and aliquots of culture supernatants were removed at
various times p.i. and analyzed by plaque assay. As
shown in Figure 9, KyADIER and wild-type KyA viruses
grew equally well on RK-13 cells, demonstrating that
the insertion of the wild-type IE gene into the genome
of the IE null virus was sufficient to restore its capacity
for growth in cell culture.
DISCUSSION
A replication-defective EHV-1 mutant containing lacZ
insertions in both copies of the IE gene was constructed
and characterized. This mutant, designated KyADIE, was
unable to propagate in cells that did not provide a func-
tional, complementing IE protein in trans. Also, the syn-
thesis of any viral protein could not be demonstrated in
cells infected with IE deletion mutant. These observa-
tions are consistent with previous data that suggested
that IE gene expression is essential for gene program-
ming because a cycloheximide block of translation of the
IE mRNA precluded detectable expression of all other
viral genes (Caughman et al., 1985). Construction of this
mutant and its failure to replicate in cells that did not
express a functional IE protein provide direct and unam-
biguous evidence that the IE gene of EHV-1 is essential
for viral growth in cell culture.
To propagate the KyADIE virus, a neomycin-resistant
cell line expressing the wild-type IE gene (designated
IE13.1) was generated and characterized. IF studies
revealed high-level expression of the IE protein within
the nuclei of IE13.1 cells, whereas Western blot anal-
ysis confirmed that the IE protein produced was full
length compared with the wild-type IE protein. The
finding that EHV-1 early promoter-CAT constructs were
transactivated upon transfection into the IE13.1 cell
line showed that the IE protein being expressed was
functional and eliminated the possibility that the trans-
activation function may have been abrogated as a
result of conformational changes arising from misfold-
ing of the IE protein. The high level of expression of
the IE protein in the IE13.1 cell line was somewhat
surprising because this protein has been demon-
strated to be a potent transactivator of EHV-1 promot-
ers as well as heterologous promoters (Smith et al.,
1992, 1993). Similarly, the IE protein ICP4, the HSV-1
homolog to the EHV-1 IE protein, has been shown to
strongly transactivate both HSV-1 viral promoters and
heterologous promoters and to affect the expression
of cellular genes (Smiley et al., 1991; Cheung et al.,
1997). However, the constitutive expression of the IE
protein during serial passages of the IE13.1 cells did
not induce cytotoxic effects leading to poor IE expres-
sion or result in reduced cell growth or cell death.
Furthermore, the IE13.1 cells did not display an altered
phenotype compared with control RK-13 cells and
were not impaired in their ability to grow robustly in
culture. The lack of cytotoxic effects associated with
expression of the EHV-1 IE protein hash also been
observed in our recently developed mouse fibroblast
cell lines that express this viral regulatory protein
(K. A. Garko-Buczynski, R. H. Smith, S. K. Kim, and D. J.
O’Callaghan, unpublished observations).
The IE13.1 cell line and the replication-deficient vi-
rus KyADIE are two critical reagents that will be used
to elucidate the functions of the IE protein during the
course of a productive infection, as well as to dissect
the essential domains that lie within this multifunc-
tional protein. The EHV-1 IE gene product shows sig-
nificant homology to a number of alphaherpesvirus
transcriptional regulatory proteins, including HSV-1
ICP4, varicella-zoster virus ORF62, pseudorabies virus
IE180, and bovine herpesvirus type 1 BICP4 (Smith et
al., 1994; Cheung, 1989; Grundy, et al., 1989; McGeoch
et al., 1986, Schwyzer et al., 1993). Sequence align-
ment of the EHV-1 IE protein and these homologs had
FIG. 9. Growth curve analyses of wild-type KyA and KyADIER. RK-13
cells were infected with either wild-type KyA (M) or KYADIER (e) at an
m.o.i. of 1 and incubated for 1 h at 37°C in 5% CO2 to allow virus
attachment. After attachment, the cells were washed three times with
PBS to remove unattached virus and were incubated at 37°C in 5% CO2.
At the times indicated after the 1 h attachment period, virus titers in the
culture supernatant were determined by plaque assay using RK-13
cells.
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defined five co-linear regions that harbor specific func-
tional domains. Two of these regions, 2 and 4, are
highly conserved and exhibit 50% amino acid identity,
whereas regions 1, 3, and 5 show a much lower level
of identity, with the exception of a serine-rich tract
found within region 1 (Cheung, 1989; Grundy, et al.,
1989; McGeoch et al., 1986, Schwyzer et al., 1993).
Despite the sequence differences in regions 1, 3, and
5, the proteins perform several similar functions during
productive infection. Recent studies have revealed
that the HSV-1 ICP4 protein is truly multifunctional and
can both interact with host regulatory proteins and
affect several cellular processes, including cellular
gene expression, apoptosis, and translocation of cel-
lular proteins (Xia et al., 1996; Leopardi and Roizman,
1996a,b; Cheung, et al., 1997; Carrozza and DeLuca,
1996; Smith et al., 1993). The domains that mediate
some of these ICP4 functions have been identified. In
the case of the EHV-1 IE protein, region 1 contains a
separable, potent transactivation domain that maps
within the first 89 amino acids (Smith et al., 1994). This
transactivation domain shows homology with the
transactivation domains of other alphaherpesvirus
ICP4 homologs as well as with the 78-amino-acid
C-terminal activation domain of the HSV-1 VP16 (virion
protein 16) gene product. Studies using EHV-1 pro-
moter probes and glutathione S-transferase fusion
proteins harboring truncated portions of the EHV-1 IE
polypeptide in gel shift and DNase I footprinting anal-
yses revealed that the DNA binding activity resides
within region 2 (amino acid residues 422–597) of this
protein of 1487 amino acids (Kim et al., 1995). A com-
parative sequence analysis of the various established
DNA binding motifs identified a sequence referred to
as the WQLN region (Tyler et al., 1994). This WQLN
region showed extensive similarity to the homeodo-
main DNA recognition helix and is highly conserved
among the alphaherpesvirus transactivator homologs.
Mutations within this WQLN region significantly af-
fected the DNA binding activity of the IE protein (Kim et
al., 1997). Last, experiments using IE nonsense mu-
tants that expressed truncated IE polypeptides dem-
onstrated that the nuclear localization signal of the IE
protein mapped within region 3 at residues 963–970
(Smith et al., 1995).
Both the IE13.1 cell line and the KyADIE null virus are
essential reagents with which to investigate the func-
tions of the IE protein with regard to transactivation,
DNA binding, and nuclear localization, as well as to
identify domains that mediate interactions of this ma-
jor regulatory protein with other viral proteins and
cellular factors that govern EHV-1 gene programming.
In addition, the use of the KyADIE null virus in the
mouse model will allow the possible role of the IE
protein as a target of the cytolytic T-lymphocyte re-
sponse to be evaluated (Smith et al., 1998). Workers in
this laboratory have generated a library of constructs
that encode forms of the IE protein harboring muta-
tions within all five regions, and a recombination sys-
tem has been established to generate viruses that
express these mutant forms of the IE protein. We hope
that ongoing experimentation with these reagents will
provide additional insights into the nature of this mul-
tifunctional viral protein.
MATERIALS AND METHODS
Plasmids
pSVIE contains the intact ORF of the EHV-1 IE gene
under the control of the Simian virus 40 (SV40) early
promoter and enhancer. Construction of this plasmid has
been described previously (Smith et al., 1992). Plasmid
pSR48 contains the bacterial gene for neomycin resis-
tance under the control of the EHV-1 thymidine kinase
(tk) promoter. Plasmid pFG65 contains 1.45 kb of the
EHV-1 IE gene promoter region (2813 to 1637 nt) fused
to the E. coli lacZ gene in a pBR322-based vector (Lewis
et al., 1993). Plasmid TK2-CAT contains the EHV-1 tk
promoter sequences from 2215 to 1133 linked to chlor-
amphenicol acetyltransferase (CAT) coding sequences
and has been described previously (Smith et al., 1992). A
recombination vector, designated pBR322IE, was gener-
ated for rescue experiments involving KyADIE. To gener-
ate the recombination vector pBR322IE, pBR322 was
digested with EcoRV and PvuII and religated to generate
pBR322E/P. An 8.0-kb NdeI fragment containing the en-
tire IE ORF from nt 2215 to nt 18140 of the
IE sequence was cloned into the sole NdeI site of
pBR322E/P to generate pBR322IE.
Cell culture and virus titration
LM cells were propagated in suspension culture with
YELP medium (Eagle’s minimum essential medium
[EMEM] supplemented with yeast extract, lactalbumin
hydrolysate, and peptone) containing 0.12% methylcellu-
lose, 100 mg/ml streptomycin, 100 U/ml penicillin, and 5%
fetal bovine serum (FBS). Rabbit kidney cells (RK-13)
were maintained in complete EMEM supplemented with
100 mg/ml streptomycin, 100 U/ml penicillin, nonessen-
tial amino acids, and 5% fetal bovine serum. Infectious
virus was measured by a plaque assay described previ-
ously (Perdue et al., 1974).
DNA transfection
RK-13 cells were plated at a density of 2.5 3 106
cells/25 cm3 in complete EMEM and permitted to at-
tach overnight at 37°C in 5% CO2. The next day, RK-13
monolayers were subjected to liposome-mediated
DNA transfection using Lipofectin reagent (GIBCO
BRL, Gaithersburg, MD) according to the manufactur-
er’s instructions. Briefly, liposomes were prepared by
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mixing 20 ml of Lipofectin reagent with 230 ml of
serum-free EMEM and incubating at room temperature
for 45 min. Up to 10 mg of DNA was prepared in a
separate tube containing 250 ml of serum-free EMEM
and gently mixed into the preformed liposome solu-
tion. For establishment of a cell line expressing the
EHV-1 IE protein, pSVIE and pSR48 were cotransfected
into RK-13 cells in ratios ranging from 1:1 to 5:1, re-
spectively, at a final amount of 10 mg. The liposome-
DNA mixture was incubated at room temperature for
an additional 15 min. During this incubation period, the
RK-13 cell monolayer was washed three times with
serum-free EMEM. The liposome-DNA solution was
added dropwise to each RK-13 cell monolayer contain-
ing 1 ml of serum-free EMEM. The cells were incu-
bated at 37°C with 5% CO2 for 5 h. Then, 5–10 ml of
EMEM supplemented with 5% FBS was added to trans-
fected cells after 5 h, and the cells were further cul-
tured at 37°C with 5% CO2 for an additional 72 h. For
cell line generation, geneticin (Sigma Chemical Co.,
St. Louis, MO) was added to a final concentration of
800 mg/ml at 24 h after transfection for selection pur-
poses. For null virus generation, RK-13 cells were
cotransfected with viral genomic DNA and plasmid
pFG65 and were incubated until cytopathic effects
(CPE) were observed before harvesting of culture su-
pernatants. Cultures were examined for CPE for a
period of up to 7 days. Culture supernatants from
transfected cells containing the progeny virus were
plated in 10-fold dilutions on confluent RK-13 cells that
express the EHV-1 IE protein (IE13.1 cells). Infected
IE13.1 cells were overlaid with 2% agarose mixed in a
1:1 ratio with 23 EMEM supplemented with 6% FBS.
BluoGal (GIBCO BRL) was added to the overlay mix-
ture at a final concentration of 1 mM to identify blue
plaques.
Immunofluorescence assays
IE13.1 cells were seeded onto two-chamber glass
slides (Nalge Nunc International, Naperville, IL) and in-
cubated overnight at 37°C in 5% CO2. The cells were
fixed in 80% acetone and blocked with normal goat
serum (1:100 in phosphate-buffered saline [PBS]). Cells
were examined by indirect immunofluorescence (IF) us-
ing an anti-IE peptide-specific polyclonal rabbit anti-
serum followed by staining with a fluorescein isothiocya-
nate-labeled goat anti-rabbit IgG (Sigma Chemical) sec-
ondary antibody as described previously (Smith et al.,
1994).
SDS-polyacylamide gel electrophoresis and Western
blot analyses
Mock-infected RK-13 cells, RK-13 cells infected with
EHV-1 at an m.o.i. of 5 pfu/cell, and IE13.1 cells were
harvested in 1 ml of RIPA buffer (150 mM NaCl, 50 mM
Tris-HCl, pH 8.0, 0.1% SDS, 0.5% deoxycholate, and
1.0% Nonidet-P40) containing protease inhibitors (50
mg/ml aprotinin, 50 mg/ml leupeptin, and 300 mg/ml
phenylmethylsulfonyl fluoride). Total protein was de-
termined by use of the bicinchoninic acid protein as-
say reagent (Pierce Chemical Co., Rockford, IL). Pro-
tein samples were boiled for 5 min with an equal
volume of 23 Laemmli’s sample buffer (10% 2-mercap-
toethanol, 4% SDS, 20% glycerol, 120 mM Tris-HCl, pH
6.8, and 0.001% bromphenol blue). Proteins were sep-
arated through a 4% stacking gel and an 8% resolving
gel. Proteins in the gel were electrophoretically trans-
ferred to a nitrocellulose membrane (Schleicher &
Schuell, Inc., Keene, NH) at 100 V for 1 h at 4°C. After
transfer, the membrane was blocked for 1 h at room
temperature in TBST buffer (100 mM Tris-HCl, pH 7.5,
0.9% NaCl, and 0.1% Tween 20) containing 1% gelatin
(Sigma Chemical). The nitrocellulose membrane then
was incubated with a polyclonal anti-IE peptide-spe-
cific antiserum (1:1000 dilution) followed by incubation
with goat anti-rabbit antibody (1:30,000 dilution; Sigma
Chemical) conjugated to alkaline phosphatase. This
anti-IE peptide antibody was generated to a peptide
spanning amino acids 425–445 of the IE protein and
has been demonstrated in previous studies to be
highly reactive to the IE protein in IF and Western blot
analyses (Smith et al., 1994). Each antibody was incu-
bated in TBST containing 0.1% gelatin for 2 h with
shaking followed by three washes with TBST contain-
ing 0.1% gelatin for 15 min with shaking. The reactive
proteins were visualized by incubating the membrane
in NBT buffer (100 mM Tris-HCl, pH 9.5, 100 mM NaCl,
5.0 mM MgCl2, 0.33 mg/ml nitroblue tetrazolium
[GIBCO BRL], and 0.165 mg/ml 5-bromo-4-chloro-3-
indolyl phosphate [GIBCO BRL]).
Polymerase chain reaction analyses of virus isolates
Virus was isolated from culture supernatants by
ultracentrifugation in an SW50.1 rotor at 28,000 rpm for
2 h at 4°C. Supernatants were aspirated, and the
remaining pellet was resuspended in 50 ml of RIPA
buffer (150 mM NaCl, 50 mM Tris-HCl, pH 8.0, 0.1%
SDS, 0.5% deoxycholate, 1% Nonidet-P40) and incu-
bated at room temperature for 1 h with occasional
mixing. Resuspended pellets served as templates for
polymerase chain reaction (PCR) analyses. IE-specific
DNA fragments were amplified using an IE forward
primer (59-CCTTCCCTTCTCGGTCTT-39; nt 913–930)
and an IE reverse primer (59-CTCCACCCCGAACAT-
GTT-39; NT 1155–1138). The lacZ-specific DNA frag-
ments were amplified using the IE forward primer
(above) and an lacZ-specific primer (59-GGGTAACGC-
CAGGGTTTT-39) derived from the 59 coding region of
the E. coli lacZ gene.
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Viral infection, isotopic labeling of infected cell
proteins, and preparation of cell extracts
Confluent monolayers of RK-13 cells in 25-cm2
flasks were infected at an m.o.i. of 20 pfu/cell with
EHV-1 KyA strain/cell or mock-infected in EMEM with
2% FBS and one-tenth the normal concentrations of
unlabeled methionine. Cultures were radiolabeled at
intervals throughout infections as specified in the text
with [35S]methionine (40 mCi/ml; specific activity, 1175
Ci/mmol; New England Nuclear Corp., Boston, MA). At
the end of each labeling interval, each culture was
washed twice with ice-cold PBS and incubated for 15
min on ice in 300 ml of RIPA buffer supplemented with
50 mg per ml of aprotinin and 30 mg/ml phenylmethyl-
sulfonyl fluoride and stored at 285°C. Aliquots of
cellular extracts corresponding to 3 3 105 cells were
boiled for 5 min and resolved on 10% SDS-polyacyl-
amide gels. After electrophoresis, the gels were fixed
overnight in an aqueous solution 10% trichloroacetic
acid followed by impregnation for 1 h with autoradio-
graphic enhancer (EN3HANCE; New England Nuclear).
Gels were dried and exposed to Kodak XAR-5 X-Omat
AR film.
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